<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01527604</url>
  </required_header>
  <id_info>
    <org_study_id>IRB9930</org_study_id>
    <nct_id>NCT01527604</nct_id>
  </id_info>
  <brief_title>Effects of Avenanthramide-enriched Oats on Inflammation</brief_title>
  <official_title>Effects of Avenanthramide-enriched Oats on Inflammation in Obese Adults With Central Adiposity: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tufts University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agriculture and Agri-Food Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tufts University</source>
  <brief_summary>
    <textblock>
      The objective of this randomized, double-blinded, placebo-controlled, parallel trial is to
      determine whether consuming avenanthramide-enriched oats daily for 8 weeks on can improve
      biomarkers of inflammation in older, obese adults.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in biomarkers of inflammation compared with placebo</measure>
    <time_frame>Baseline and 8 weeks</time_frame>
    <description>Primary outcome measures will include selected biomarkers of inflammation in blood, i.e., pro-inflammatory cytokines, chemokines, as well as other inflammatory markers (i.e., high sensitivity C-reactive protein).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in biomarkers of glucoregulation, plasma lipids, and blood pressure compared with placebo</measure>
    <time_frame>Baseline and 8 weeks</time_frame>
    <description>Secondary outcomes will include plasma markers of glucoregulation (fasting glucose, insulin, HOMA), plasma lipids (total cholesterol, HDL, LDL, triglycerides), and blood pressure (BP).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>Avenanthramide-enriched oat muffin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Refined flour muffin</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Avenanthramide-enriched oats</intervention_name>
    <description>avenanthramide-enriched oats, delivered as muffins at a dose of 2 muffins per day for 56 days.</description>
    <arm_group_label>Avenanthramide-enriched oat muffin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Refined flour absent avenanthramides</intervention_name>
    <description>refined flour absent avenanthramides, delivered as muffins at a dose of 2 muffins per day for 56 days.</description>
    <arm_group_label>Refined flour muffin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men &amp; postmenopausal women, age 50 years and over

          -  BMI 30-36 kg/m2

          -  waist:hip ratio &gt; 0.8 for women, &gt; 0.9 for men

        Exclusion Criteria:

          -  Cigarette smoking and/or nicotine replacement use

          -  Individuals taking estrogen

          -  Use of cholesterol-lowering medications

          -  Use of blood pressure-lowering medications

          -  Regular use of any stomach acid-lowering medications, laxatives (including fiber
             supplements) or anti-diarrheal medications(prescription or over-the-counter [OTC])

          -  Cardiovascular (heart) disease

          -  Gastrointestinal disease

          -  Kidney disease

          -  Endocrine disease: including diabetes, untreated thyroid disease

          -  Rheumatoid arthritis

          -  Active treatment for any type of cancer, except basal cell carcinoma, within 1 year
             prior to study admission

          -  Systolic blood pressure &gt; 150 mmHg and/or diastolic blood pressure &gt; 95 mmHg

          -  Regular use of oral steroids

          -  Regular daily intake of â‰¥ 2 alcoholic drinks

          -  Strict vegetarians

          -  No dietary supplements, including those containing any vitamins, minerals, herbs,
             plant concentrates (including garlic, gingko, St. John's wort) homeopathic remedies,
             probiotics, or fish oil (including cod liver oil), for one month prior to study
             admission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diane L. McKay, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tufts Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2012</study_first_submitted>
  <study_first_submitted_qc>February 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2012</study_first_posted>
  <last_update_submitted>November 18, 2014</last_update_submitted>
  <last_update_submitted_qc>November 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

